Layer, Chiang, et al. Genome Biology
UT Southwestern Team Uncovers Role of miRNA in Slowing ALS Progression
Miragen Therapeutics, which holds the rights to the discovery, is interested in seeing the work advance. But a company official said that development of a miRNA-targeting drug for ALS would likely only occur in earnest with a partner.
New to GenomeWeb? Register here quickly.